Skip to main content

Pacira BioSciences, Inc.

PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001396814

In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 265 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Pacira BioSciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $70.6K in total
Insiders trading
1
Net value
−$70.6K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Pacira BioSciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Pacira BioSciences, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Slonin JonathanChief Medical Officer216,384Aug 18, 20267
Wiggans Thomas GDirector–Jun 12, 20261
Brege LauraDirector30,120Jun 12, 20261
Riker Lauren BullaroSenior Vice President, Finance62,284Jun 12, 20265
Yang Michael J.Director19,798Jun 12, 20261
Froimson MarkDirector26,541Jun 12, 20262
Hirawat SamitDirector6,405Jun 12, 20262
Christie ChristopherDirector23,059Jun 12, 20261
Young AlethiaDirector17,798Jun 12, 20261
Bigal MarceloDirector17,798Jun 12, 20261
Williams Kristen MarieChief Administrative Officer167,062Jun 5, 20263
Cross ShawnChief Financial Officer105,341Apr 24, 20266
Kronenfeld Mark A.Director31,065Mar 19, 20261
Lee Frank D.Chief Executive Officer660,831Feb 13, 20263
Teehan BrendanChief Commercial Officer100,934Feb 13, 20263
Ceesay AbrahamDirector9,039Sep 8, 20250
Gaugler DarylChief Operating Officer115,443Jan 6, 20250
Hastings Paul JDirector12,724Jun 13, 20240
Reinhart Charles A. IIIChief Financial Officer51,867Jun 13, 20240
Pace Gary WDirector22,127Mar 8, 20240
Winston RoyChief Medical Officer52,440Aug 4, 20230
Stack David MCEO and Chairman186,481Jun 16, 20230
McLoughlin DennisChief Customer Officer38,115Jun 7, 20230
Reinhardt MaxPresident, Rest of World29,225Jun 7, 20230
Ellis Ronald J. Jr.Chief Strategy Officer30,909Jun 7, 20230
Molloy AnthonyChief Lgl & Compliance Officer12,877Jun 7, 20230
Laranjeira Charles AnthonyChief Technical Officer41,752Jun 16, 20220
Greenstreet YvonneDirector13,247Jun 8, 20220
Longenecker John P PhDDirector18,823Mar 7, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 18, 2026 (view filing)5:21 PM ETAug 171 daySlonin JonathanChief Medical OfficerSSale−3.04K$23.23−$70.6K−1.4%216.4K after10b5-1
Jun 12, 2026 (view filing)Jun 111 dayRiker Lauren BullaroSenior Vice President, FinanceSSale−6.12K$23.50−$143.7K−8.9%62.3K after10b5-1
Jun 5, 2026 (view filing)Jun 41 dayWilliams Kristen MarieChief Administrative OfficerSSale−10.3K$22.27−$228.5K−5.8%167.1K after10b5-1
Apr 24, 2026 (view filing)Apr 231 dayCross ShawnChief Financial OfficerSSale−12.9K$25.16−$325.6K−10.9%105.3K after10b5-1
Apr 22, 2026 (view filing)Apr 20-222 daysCross ShawnChief Financial OfficerSSale−12.1K$25.09−$302.6K−10.3%105.3K after3 lots10b5-1
Mar 19, 2026 (view filing)Mar 172 daysSlonin JonathanChief Medical OfficerSSale−3.26K$22.82−$74.4K−1.4%223.6K after10b5-1
Mar 19, 2026 (view filing)Mar 172 daysFroimson MarkDirectorSSale−500$21.81−$10.9K−2.4%20.1K after
Feb 3, 2026 (view filing)Feb 21 dayRiker Lauren BullaroSenior Vice President, FinanceSSale−4.00K$20.81−$83.2K−7.1%52.3K after10b5-1
Feb 3, 2026 (view filing)Feb 21 dayWilliams Kristen MarieChief Administrative OfficerSSale−13.1K$20.53−$269.7K−9.1%131.3K after10b5-1
Jan 6, 2026 (view filing)Jan 51 dayRiker Lauren BullaroSenior Vice President, FinanceSSale−1.42K$24.24−$34.3K−2.3%59.1K after10b5-1
Dec 11, 2025 (view filing)Dec 9-102 daysCross ShawnChief Financial OfficerSSale−25.0K$25.07−$626.8K−30.8%56.3K after2 lots10b5-1
Nov 19, 2025 (view filing)Nov 172 daysSlonin JonathanChief Medical OfficerSSale−3.96K$24.09−$95.4K−2.2%178.4K after10b5-1
Nov 13, 2025 (view filing)Nov 103 daysCross ShawnChief Financial OfficerSSale−12.1K$22.09−$266.4K−17.7%56.3K after10b5-1
Sep 8, 2025 (view filing)Sep 44 daysCeesay AbrahamDirectorSSale−2.35K$27.19−$64.0K−20.7%9.04K after10b5-1
Aug 11, 2025 (view filing)Aug 74 daysBigal MarceloDirectorSSale−4.91K$23.67−$116.3K−30.1%11.4K after
Jun 5, 2025 (view filing)Jun 41 dayRiker Lauren BullaroSenior Vice President, FinanceSSale−5.58K$26.21−$146.2K−8.6%59.6K after
Jun 5, 2025 (view filing)Jun 41 dayWilliams Kristen MarieChief Administrative OfficerSSale−14.4K$26.24−$377.2K−8.2%161.6K after
Jan 6, 2025 (view filing)Jan 6Same daySlonin JonathanChief Medical OfficerSSale−879$18.40−$16.2K−0.9%93.4K after10b5-1
Dec 16, 2024 (view filing)Dec 133 daysGaugler DarylChief Operating OfficerSSale−500$19.76−$9.88K−0.4%115.2K after10b5-1
Sep 13, 2024 (view filing)Sep 13Same dayGaugler DarylChief Operating OfficerSSale−500$12.86−$6.43K−0.4%115.7K after10b5-1
Aug 19, 2024 (view filing)Aug 163 daysBigal MarceloDirectorPPurchase+1.51K$13.25+$20.0K+17.5%10.1K after
Aug 19, 2024 (view filing)Aug 163 daysBrege LauraDirectorPPurchase+1.00K$12.81+$12.8K+6.0%17.6K after
Aug 14, 2024 (view filing)Aug 14Same dayYang Michael J.DirectorPPurchase+2.00K$12.90+$25.8K+38.2%7.23K after
Aug 13, 2024 (view filing)Aug 121 dayLee Frank D.Chief Executive OfficerPPurchase+8.26K$12.10+$100.0K+8.3%107.8K after
Aug 13, 2024 (view filing)Aug 121 dayBigal MarceloDirectorPPurchase+3.40K$12.01+$40.8K+65.0%8.63K afterAmended
Aug 12, 2024 (view filing)Aug 12Same dayFroimson MarkDirectorPPurchase+1.40K$11.58+$16.2K+10.7%14.5K after
Aug 2, 2024 (view filing)Aug 2Same daySlonin JonathanChief Medical OfficerSSale−945$20.05−$18.9K−1.0%94.3K after10b5-1
Jul 3, 2024 (view filing)Jul 21 daySlonin JonathanChief Medical OfficerSSale−2.84K$28.25−$80.1K−2.9%95.6K after10b5-1
Jun 13, 2024 (view filing)Jun 121 dayRiker Lauren BullaroSenior Vice President, FinanceSSale−3.97K$28.72−$114.0K−9.4%38.1K after10b5-1
Jun 13, 2024 (view filing)Jun 112 daysSlonin JonathanChief Medical OfficerSSale−5.01K$28.57−$143.2K−10.1%44.6K after10b5-1
Jun 13, 2024 (view filing)Jun 13Same dayGaugler DarylChief Operating OfficerSSale−1.00K$28.38−$28.4K−0.9%116.0K after10b5-1
Jun 13, 2024 (view filing)Jun 13Same dayHastings Paul JDirectorSSale−880$28.38−$25.0K−6.5%12.7K after10b5-1
Jun 13, 2024 (view filing)Jun 13Same dayWilliams Kristen MarieChief Administrative OfficerSSale−7.45K$28.38−$211.5K−6.8%102.9K after10b5-1
Mar 8, 2024 (view filing)Mar 6-82 daysPace Gary WDirectorSSale−119.3K$30.64−$3.66M−84.4%22.1K after3 lots
Aug 4, 2023 (view filing)Aug 22 daysWinston RoyChief Medical OfficerSSale−509$34.88−$17.8K−1.0%52.4K after
Jul 7, 2023 (view filing)Jul 52 daysRiker Lauren BullaroSenior Vice President, FinanceSSale−643$38.91−$25.0K−2.8%22.7K after10b5-1
Jun 16, 2023 (view filing)Jun 142 daysWilliams Kristen MarieChief Administrative OfficerSSale−6.47K$37.03−$239.5K−20.3%25.4K after10b5-1
Jun 16, 2023 (view filing)Jun 142 daysRiker Lauren BullaroSenior Vice President, FinanceSSale−6.37K$38.42−$244.6K−21.9%22.7K after3 lots10b5-1
Jun 12, 2023 (view filing)Jun 84 daysKronenfeld Mark A.DirectorSSale−15.0K$37.04−$555.6K−45.6%17.9K after10b5-1
Jun 7, 2023 (view filing)Jun 6-71 dayWinston RoyChief Medical OfficerSSale−3.64K$38.42−$139.7K−8.1%41.4K after2 lots
Jun 7, 2023 (view filing)Jun 6-71 dayWilliams Kristen MarieChief Administrative OfficerSSale−2.66K$38.42−$102.1K−11.3%20.9K after2 lots
Jun 7, 2023 (view filing)Jun 6-71 dayStack David MCEO and ChairmanSSale−10.4K$38.42−$398.9K−6.3%153.8K after2 lots
Jun 7, 2023 (view filing)Jun 6-71 daySlonin JonathanChief Clinical OfficerSSale−961$38.42−$36.9K−2.6%36.3K after2 lots
Jun 7, 2023 (view filing)Jun 6-71 dayRiker Lauren BullaroSenior Vice President, FinanceSSale−1.21K$38.42−$46.4K−6.0%19.1K after2 lots
Jun 7, 2023 (view filing)Jun 6-71 dayReinhart Charles A. IIIChief Financial OfficerSSale−2.61K$38.40−$100.1K−7.2%33.6K after2 lots
Jun 7, 2023 (view filing)Jun 6-71 dayReinhardt MaxPresident, Rest of WorldSSale−2.15K$38.42−$82.7K−6.9%29.2K after2 lots
Jun 7, 2023 (view filing)Jun 5-62 daysMolloy AnthonyChief Lgl & Compliance OfficerSSale−6.79K$38.46−$261.1K−34.5%12.9K after2 lots10b5-1
Jun 7, 2023 (view filing)Jun 6-71 dayMcLoughlin DennisChief Customer OfficerSSale−2.07K$38.42−$79.6K−5.2%38.1K after2 lots
Jun 7, 2023 (view filing)Jun 52 daysHastings Paul JDirectorSSale−580$38.34−$22.2K−8.1%6.60K after
Jun 7, 2023 (view filing)Jun 5-72 daysGaugler DarylChief Operating OfficerSSale−3.05K$38.52−$117.6K−12.4%21.5K after3 lots10b5-1